ArticleEuropean journal of public health2024
Comparative evaluation of access to emicizumab (Hemlibra®) for people with haemophilia A in community and hospital pharmacies in France.
Morgane Cabon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.